Literature DB >> 6813123

Thyroid function in children with cystic fibrosis.

F De Luca, F Trimarchi, C Sferlazzas, S Benvenga, G Costante, C Mami, G Di Pasquale, G Magazzu.   

Abstract

Serum concentrations of T4, T3, reverse T3 (rT3), TSH, Thyroxine binding globulin (TBG) and Thyroxine binding prealbumin (TBPA) were measured and a TRH-stimulation test was performed in 10 iodide untreated children affected by cystic fibrosis (CF) and in 84 controls. As compared to the controls, CF patients had lower T4 and rT3, similar T3 and TBG and increased T3:T4 ratios. They also had lower TBPA, but this could not account for the low T4. Finally they had higher basal and TRH-stimulated TSH. Our results indicate subclinical hypothyroidism in CF. The mechanisms responsible for this situation are not elucidated by our data.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6813123     DOI: 10.1007/bf00442510

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Increased serum TSH response to TRH in cystic fibrosis.

Authors:  D Baran; R Wolter; P Bourdoux; A M Ermans
Journal:  Monogr Paediatr       Date:  1979

2.  Thyroxine metabolism in untreated and treated pancreatic steatorrhea.

Authors:  J M HISS; J T DOWLING
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

3.  Human serum retinol transport in malabsorption.

Authors:  F R Smith; J Lindenbaum
Journal:  Am J Clin Nutr       Date:  1974-07       Impact factor: 7.045

4.  Classification of nutritional status in early childhood.

Authors:  D S McLaren; W W Read
Journal:  Lancet       Date:  1972-07-22       Impact factor: 79.321

5.  Complications of iodide therapy in patients with cystic fibrosis.

Authors:  T F Dolan; L E Gibson
Journal:  J Pediatr       Date:  1971-10       Impact factor: 4.406

6.  Controlled study of iodotherapy for childhood asthma.

Authors:  C J Falliers; W P McCann; H Chai; E F Ellis; N Yazdi
Journal:  J Allergy       Date:  1966-09

7.  [Changes of the plasma levels of thyroid hormones in patients with cystic fibrosis].

Authors:  P Rubio Pérez; M L Sánchez Sánchez; A Durán Escribano; E Calvo Manuel; J Gallardo López; J Millán Núñez-Cortés
Journal:  Rev Clin Esp       Date:  1979-12-31       Impact factor: 1.556

8.  High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease.

Authors:  F Bermudez; M I Surks; J H Oppenheimer
Journal:  J Clin Endocrinol Metab       Date:  1975-07       Impact factor: 5.958

9.  [Reciprocal changes in T3 nd rT3 serum concentrations in digestive diseases resulting in childhood protein-calorie malnutrition (author's transl)].

Authors:  F Trimarchi; R Melluso; G Sobbrio; C Mami; F de Luca
Journal:  Ann Endocrinol (Paris)       Date:  1980 Sep-Oct       Impact factor: 2.478

10.  Thyroid function in thalassaemia major.

Authors:  F de Luca; R Melluso; G Sobbrio; G Canfora; F Trimarchi
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

View more
  12 in total

1.  Endogenous surface expression of ΔF508-CFTR mediates cAMP-stimulated Cl(-) current in CFTR(ΔF508/ΔF508) pig thyroid epithelial cells.

Authors:  Yonghai Li; Suhasini Ganta; Peying Fong
Journal:  Exp Physiol       Date:  2011-09-23       Impact factor: 2.969

2.  Altered ion transport by thyroid epithelia from CFTR(-/-) pigs suggests mechanisms for hypothyroidism in cystic fibrosis.

Authors:  Hui Li; Suhasini Ganta; Peying Fong
Journal:  Exp Physiol       Date:  2010-08-20       Impact factor: 2.969

Review 3.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 4.  Pulmonary hypertension survival effects and treatment options in cystic fibrosis.

Authors:  Adriano R Tonelli
Journal:  Curr Opin Pulm Med       Date:  2013-11       Impact factor: 3.155

Review 5.  Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.

Authors:  Oranan Siwamogsatham; Jessica A Alvarez; Vin Tangpricha
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

6.  Hyperthyrotropinemia in newly diagnosed cystic fibrosis patients with pancreatic insufficiency reversed by enzyme therapy.

Authors:  Aris Giannakopoulos; Anni Katelaris; Maria Noni; Theodore Karakonstantakis; Christina Kanaka-Gantenbein; Stavros Doudounakis
Journal:  Eur J Pediatr       Date:  2018-02-27       Impact factor: 3.183

7.  Thyroid Function in Patients with Cystic Fibrosis: No Longer a Concern?

Authors:  Sun Y Lee; Supavit Chesdachai; Moon J Lee; Xue-Mei He; Vin Tangpricha; Lewis E Braverman
Journal:  Thyroid       Date:  2016-05-19       Impact factor: 6.568

8.  Acute inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel by thyroid hormones involves multiple mechanisms.

Authors:  Zhiwei Cai; Hongyu Li; Jeng-Haur Chen; David N Sheppard
Journal:  Am J Physiol Cell Physiol       Date:  2013-06-19       Impact factor: 4.249

9.  A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12.

Authors:  Matteo Bianchi; Stina Dahlgren; Jonathan Massey; Elisabeth Dietschi; Marcin Kierczak; Martine Lund-Ziener; Katarina Sundberg; Stein Istre Thoresen; Olle Kämpe; Göran Andersson; William E R Ollier; Åke Hedhammar; Tosso Leeb; Kerstin Lindblad-Toh; Lorna J Kennedy; Frode Lingaas; Gerli Rosengren Pielberg
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

10.  Skin Biomarkers for Cystic Fibrosis: A Potential Non-Invasive Approach for Patient Screening.

Authors:  Cibele Zanardi Esteves; Letícia de Aguiar Dias; Estela de Oliveira Lima; Diogo Noin de Oliveira; Carlos Fernando Odir Rodrigues Melo; Jeany Delafiori; Carla Cristina Souza Gomez; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Carlos Emílio Levy; Rodrigo Ramos Catharino
Journal:  Front Pediatr       Date:  2018-01-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.